Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urethane SCHEMBL16671173 | 0.90 | ALOX15 (0.56) | ALOX15LMNAALDH1A1KDM4EDUSP3 | |
| Urethane SCHEMBL28942676 | 0.88 | ALOX15 (0.58) | ALOX15LMNAALDH1A1KDM4EDUSP3 | |
| Urethane SCHEMBL19970439 | 0.86 | ALOX15 (0.68) | ALOX15LMNAALDH1A1HSD17B10MGAM | |
| Urethane SCHEMBL28401207 | 0.86 | ALOX15 (0.68) | ALOX15LMNAALDH1A1HSD17B10MGAM | |
| Acetoacetic Acid SCHEMBL8999874 | 0.86 | ALOX15 (0.50) | ALOX15LMNAALDH1A1KDM4EDUSP3 | |
| Sebacic Acid SCHEMBL18323023 | 0.86 | ALOX15 (0.50) | ALOX15LMNAALDH1A1KDM4EDUSP3 | |
| Urethane SCHEMBL28091758 | 0.83 | ALOX15 (0.79) | ALOX15LMNAALDH1A1HSD17B10MGAM | |
| Urethane SCHEMBL28110737 | 0.83 | — | — | |
| Urethane SCHEMBL462241 | 0.83 | — | — | |
| Urethane SCHEMBL8136 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186600-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2025-06-12 | — | — | US | disclosed |
| US-20230270864-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2023-08-31 | — | — | US | disclosed |
| EP-4210757-A2 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | Comera Life Sciences, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023091370-A1 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | COMERA LIFE SCIENCES, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20230027396-A1 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2023-01-26 | — | — | US | disclosed |
| US-20220401559-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2022-12-22 | — | — | US | disclosed |
| EP-4065166-A1 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | Comera Life Sciences, Inc. (US) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022056220-A2 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | REFORM BIOLOGICS, INC. (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220062423-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2022-03-03 | — | — | US | disclosed |
| US-20210379185-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING | COMERA LIFE SCIENCES, INC. | 2021-12-09 | — | — | US | disclosed |
| WO-2021072050-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | REFORM BIOLOGICS, LLC (US) | 2021-04-15 | — | — | WO | disclosed |
| EP-3761962-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | Reform Biologics, LLC (US) | 2021-01-13 | — | — | EP | disclosed |
| WO-2020112855-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING | REFORM BIOLOGICS, LLC (US) | 2020-06-04 | — | — | WO | disclosed |
| WO-2019173338-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | REFORM BIOLOGICS, LLC (US) | 2019-09-12 | — | — | WO | disclosed |
| US-8921261-B2 | Catalyst for synthesizing glycerol carbonate from glycerol, method for producing the catalyst and method for synthesizing glycerol carbonate from glycerol using the catalyst | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KITECH) (KR) | 2014-12-30 | — | — | US | disclosed |
| CN-103357394-A | Catalyst for synthesizing glycerol carbonate from glycerol, method for producing the catalyst and method for synthesizing glycerol carbonate from glycerol using the catalyst | KOREA IND TECH INST | 2013-10-23 | — | — | CN | disclosed |
| US-20130267715-A1 | CATALYST FOR SYNTHESIZING GLYCEROL CARBONATE FROM GLYCEROL, METHOD FOR PRODUCING THE CATALYST AND METHOD FOR SYNTHESIZING GLYCEROL CARBONATE FROM GLYCEROL USING THE CATALYST | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KITECH) (KR) | 2013-10-10 | — | — | US | disclosed |
| EP-0914661-A1 | CONDUCTIVE COMPOSITE ARTICLES BASED ON EXPANDABLE AND CONTRACTIBLE PARTICULATE MATRICES | ZMS, LLC (US) | 1999-05-12 | — | — | EP | disclosed |
| EP-0914661-A4 | — | — | 1999-05-12 | — | — | EP | disclosed |
| WO-1997015932-A1 | CONDUCTIVE COMPOSITE ARTICLES BASED ON EXPANDABLE AND CONTRACTIBLE PARTICULATE MATRICES | ZMS, LLC (US) | 1997-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130267715-A1 | CATALYST FOR SYNTHESIZING GLYCEROL CARBONATE FROM GLYCEROL, METHOD FOR PRODUCING THE CATALYST AND METHOD FOR SYNTHESIZING GLYCEROL CARBONATE FROM GLYCEROL USING THE CATALYST | GK, GLA, AGK | ALOX15 635/4885LMNA 3769/4885ALDH1A1 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.